Evaluation of tumor-infiltrating lymphocytes, PD-L1, and < em > PIK3CA < /em > mutations and association with prognosis in HER2-positive early stage breast cancer

DISCUSSION: Patients with low sTILs had a significantly poorer survival, despite adequate treatment with adjuvant therapy.PMID:37961947 | DOI:10.1080/0284186X.2023.2279685

Source: Acta Oncologica - November 14, 2023 Category: Cancer & Oncology Authors: Frances M Reznitsky Jeanette D Jensen Ann Knoop Maj-Britt Jensen Anne-Vibeke Laenkholm Source Type: research